Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy.

However, and although it did not reach statistical significance, we could detect an increment in the incidence of micrometastasis in the CHT when treated with bevacizumab (Fig. 7n from ~8% to ~23%, ~2.8 times more micrometastasis, P = 0.11 Fisher’s exact test, g = 0.42).

also in 111,027 other papers